SCHEMBL29636642

SCHEMBL29636642

NCCC(N)c1cc(-c2ccc(C3CCNCC3)cc2)nc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.45
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.43
MAPK1 P28482 2/20 0.43
CYP1A2 P05177 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
BMPR1B O00238 1/20 0.40
BMPR1A P36894 1/20 0.40
ACVR1B P36896 1/20 0.40
ACVRL1 P37023 1/20 0.40
ACVR1 Q04771 1/20 0.40
SLC18A3 Q16572 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
SYK P43405 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015138 1.00 DHODH (0.45) DHODHCYP2D6CYP2C19MAPK1CYP1A2
SCHEMBL28967174 0.84 KMT2A (0.42) CYP2D6CYP2C19MAPK1CYP1A2MEN1
SCHEMBL29636644 0.84 KMT2A (0.42) CYP2D6CYP2C19MAPK1CYP1A2MEN1
SCHEMBL23015145 0.81 ALDH1A1 (0.47) DHODHMAPK1MAPTALDH1A1HPGD
SCHEMBL29874965 0.81 ALDH1A1 (0.47) DHODHMAPK1MAPTALDH1A1HPGD
SCHEMBL23015213 0.79 MET (0.48) CYP2C19CYP1A2
SCHEMBL29636634 0.79 MET (0.48) CYP2C19CYP1A2
SCHEMBL10730742 0.79 ACP1 (0.45) CYP2D6CYP2C19MAPK1CYP1A2MEN1
SCHEMBL23029691 0.77 ACP1 (0.58) ACP1
SCHEMBL28967193 0.75 ALDH1A1 (0.59) CYP2D6CYP2C19MAPK1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP claimed